A

Artelo Biosciences, Inc.

17 employees

Artelo Biosciences aims to accelerate the development and commercialization of endocannabinoid system modulating therapeutics.

Basic info

pharmaceutical manufacturing

Biotechnology

Pharmaceutical

synthetic cannabinoids

Life Science

CBD

FABP5 inhibitors

Oncology

Endocannabinoid Modulation

2017